Lira Pharma is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.44M and a net result of €211k. Equity is growing by ~24.8% per year across the filed fiscal years. Its solvency ranks better than 51% of 5521 sector peers (fiscal year 2025). The company has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
○neutral
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 8 filingsDeviation from the deadline
2025
18 d late
2024
19 d late
2023
21 d late
2022
4 d early
2021
22 d late
2020
23 d late
2019
18 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€1.44M▲ 17.2%
2024 · €1.23M
2018: €154k
2019: €302k
2020: €466k
2021: €642k
2022: €855k
2023: €1.04M
2024: €1.23M
2018 → 2025
Net result
€211k▲ 12.8%
2024 · €187k
2018: €135k
2019: €148k
2020: €163k
2021: €176k
2022: €213k
2023: €185k
2024: €187k
2018 → 2025
Total assets
€2.72M▲ 1.4%
2024 · €2.69M
2018: €2.64M
2019: €2.74M
2020: €2.74M
2021: €2.66M
2022: €2.73M
2023: €2.75M
2024: €2.69M
2018 → 2025
Solvency
52.8%▲ 7.1pp
2024 · 45.6%
2018: 5.8%
2019: 11.0%
2020: 17.0%
2021: 24.1%
2022: 31.4%
2023: 37.8%
2024: 45.6%
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€642k-€855k▲ 33.2%€1.04M▲ 21.6%€1.23M▲ 18.0%€1.44M▲ 17.2%
Operating result€281k-€334k▲ 18.7%€301k▼ 9.7%€301k▼ 0.1%€330k▲ 9.7%
Net result€176k-€213k▲ 20.9%€185k▼ 13.2%€187k▲ 1.1%€211k▲ 12.8%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 10% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.72M
Fixed assets
€2.58M=
Current assets
€141k▲ 35.5%
Equity and liabilities €2.72M
Equity
€1.44M▲ 17.2%
Debt
€1.29M▼ 11.9%
The debt ratio falls from 54.4% to 47.2%. Equity is higher and debt is lower.
Key figures and ratios
Solvency
52.8%▲
2024 · 45.6%
ROE
14.7%▼
2024 · 15.2%
ROA
7.7%▲
2024 · 7.0%
Debt
€1.29M▼
2024 · €1.46M
Debt ≤ 1 year
€198k▲
2024 · €190k
Debt > 1 year
€1.08M▼
2024 · €1.26M
Income taxes
€92k▲
2024 · €81k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.69M€2.72M▲
Fixed assets21/28€2.58M€2.58M=
Financial fixed assets28€2.58M€2.58M=
Current assets29/58€104k€141k▲
Amounts receivable within one year40/41€18k€67k▲
Trade receivables40€18k€18k=
Other amounts receivable41€0€49k▲
Cash at bank and in hand54/58€86k€72k▼
Deferred charges and accrued income490/1€355€2k▲
Equity and liabilities
Total equity and liabilities10/49€2.69M€2.72M▲
Equity10/15€1.23M€1.44M▲
Contributions10/11€19k€19k=
Reserves13€1.21M€1.42M▲
Distributable reserves133€1.21M€1.42M▲
Amounts payable17/49€1.46M€1.29M▼
Amounts payable after more than one year17€1.26M€1.08M▼
Financial debts170/4€1.26M€1.08M▼
Amounts payable within one year42/48€190k€198k▲
Current portion of amounts payable after more than one year42€148k€151k▲
Trade debts44€1k€1k▲
Suppliers440/4€1k€1k▲
Taxes, remuneration and social security45€37k€45k▲
Taxes450/3€37k€45k▲
Other amounts payable47/48€3k€1k▼
Accrued charges and deferred income492/3€10k€4k▼
Income statement
Code20242025
Other operating charges640/8€203€296▲
Gross operating margin9900€301k€331k▲
Operating profit (loss)9901€301k€330k▲
Financial charges65/66B€33k€27k▼
Recurring financial charges65€33k€27k▼
Profit (loss) for the period before taxes9903€268k€303k▲
Income taxes67/77€81k€92k▲
Profit (loss) for the period9904€187k€211k▲
Profit (loss) for the period to be appropriated9905€187k€211k▲
Appropriation of the result
Profit (loss) to be appropriated9906€187k€211k▲
Transfer to equity691/2€187k€211k▲
To other reserves6921€187k€211k▲
The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
18-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 18 days late
2025
19-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 19 days late
2024
21-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 21 days late
2023
31-12
Financial
Equity above €1MEq €1.04M ▲21.6%
6 profitable years in a row build equity to €1.04M.
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Highest result since 2018net €213k ▲20.9%
Operating result €334k, net result €213k, both a record.
22-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 22 days late
2021
31-12
Financial
Equity above €500kEq €642k ▲37.9%
4 profitable years in a row build equity to €642k.
23-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 23 days late
2020
18-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 18 days late
2019
31-12
Financial
Equity above €200kEq €302k ▲96.1%
2 profitable years in a row build equity to €302k.
16-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 16 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Grobbendonk · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Astridplein 702280 GrobbendonkGround area
245 m²
Building footprint
139 m²
Volume, LiDAR
918 m³
Parcel 13010B0394/00E000, Flanders · tallest building 10.7 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Lira Pharma
since 20182.272.331.106
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13010B0394/00E000 | Flanders | 245 m² | 1 · 139 m² | 10.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DomTomCo
BE 0784.229.756
Kortrijk · Eq €1.44M
THIJS-PETERS
BE 0788.386.009
Maasmechelen · Eq €1.44M
Group Ela
BE 0666.983.480
Ham · Eq €1.44M
ERIKA REDEL
BE 0896.867.146
Lievegem · Eq €1.44M
HELAXE
BE 0438.986.366
Izegem · Eq €1.44M
Of 24,728 companies in sector 64210 we hold annual accounts for 19,760. 11,868 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-11-2017
Fiscal year end31-12
Activities, NACEBEL
64200Holdings
64210Activities of holding companies
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:info@sempels.be